Appili Therapeutics Inc. reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was CAD 0.478397 million. Revenue was CAD 0.483975 million compared to CAD 0.009349 million a year ago. Net loss was CAD 0.152336 million compared to CAD 2.62 million a year ago.
For the nine months, sales was CAD 0.81571 million. Revenue was CAD 0.83196 million compared to CAD 0.023274 million a year ago. Net loss was CAD 2.68 million compared to CAD 6.58 million a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.06 a year ago.